首页 | 本学科首页   官方微博 | 高级检索  
     检索      


Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation,Optimization and In Vivo Characterization
Authors:Amarjitsing Rajput  Riyaz Ali M Osmani  Achyut Khire  Sanket Jaiswal  Rinti Banerjee
Institution:1.Nanomedicine Lab, Department of Biosciences and Bioengineering (BSBE), Indian Institute of Technology Bombay (IITB), Mumbai 400076, India; (A.K.); (S.J.); (R.B.);2.Department of Pharmaceutics, Poona College of Pharmacy, Bharti Vidyapeeth Deemed University, Pune 411038, India;3.Department of Pharmaceutics, JSS College of Pharmacy (JSSCP), JSS Academy of Higher Education & Research (JSS AHER), Mysuru 570015, India
Abstract:Background: The goal of this work was to develop a levonorgestrel liposome-loaded microneedle array patch for contraception. Methods: Levonorgestrel-loaded liposome was formulated by a solvent injection technique, characterized, and studied. Results: The formulated liposomes were characterized for particle size (147 ± 8 nm), polydispersity index (0.207 ± 0.03), zeta potential (−23 ± 4.25 mV), drug loading (18 ± 3.22%) and entrapment efficiency (85 ± 4.34%). A cryo high-resolution transmission electron microscopy and cryo field emission gun scanning electron microscopy study showed spherical shaped particles with a smooth surface. The in vitro drug release and in vivo pharmacokinetic study showed sustained behaviour of Levonorgestrel for 28 days. Conclusion: The levonorgestrel liposome-loaded microneedle array patch showed better contraception than the drug-loaded microneedle array patch.
Keywords:drug delivery  nanotechnology  contraception  levonorgestrel  liposomes  microneedle  sustained-release
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号